Blood thinner study after heart valve repair
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests different blood-thinning medicines after a mitral valve repair procedure (TEER) in people who do not need long-term blood thinners. It aims to find the safest and most effective strategy to prevent blood clots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a successful mitral valve repair with a TEER procedure.
- You must not need long-term blood thinners for another condition.
- You cannot have severe kidney disease or be on dialysis.
- You cannot have had a recent stroke, bleeding ulcer, or stomach bleed in the past year.
- You must not have a low platelet count or serious liver disease.
- You must not be pregnant or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different ways to use blood thinners after a minimally invasive heart valve repair procedure. It may help patients who need long-term blood thinning to prevent clots or stroke.
This study compares different ways of using blood thinners during procedures to fix a leaky mitral valve or close the left atrial appendage. The goal is to find the safest approach to prevent strokes and bleeding.
This trial studies which blood-thinning medicine combination is safest and most helpful after coronary bypass surgery combined with a procedure to unblock the artery (endarterectomy). It focuses on preventing dangerous blood clots while also avoiding excess bleeding.
This trial is testing whether a newer type of blood thinner (called a NOAC) can be used safely right after a heart attack or related event, in addition to the standard two antiplatelet medicines. It focuses on patients who have higher risk signs, like elevated D-dimer levels or a higher PARIS risk score, to see if this approach is safe and effective at preventing future heart problems.
This trial compares two medicines to prevent blood clots after heart valve surgery. If you've had a tissue valve replaced or repaired, this study will see if a newer blood thinner (rivaroxaban) is safer and works better than the standard treatment.
This trial compares two blood-thinning treatments after aortic valve replacement with a tissue valve. It tests if a convenient pill (apixaban) is as safe and effective as aspirin alone, to prevent blood clots and other complications. Participation could help improve recovery and reduce the risk of strokes and bleeding.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.